YU205182A - Process for obtaining 1,1-dioxide of 2-beta-subst.-2-alpha-methyl (5r)penam-3-alpha-carboxylic acid - Google Patents

Process for obtaining 1,1-dioxide of 2-beta-subst.-2-alpha-methyl (5r)penam-3-alpha-carboxylic acid

Info

Publication number
YU205182A
YU205182A YU02051/82A YU205182A YU205182A YU 205182 A YU205182 A YU 205182A YU 02051/82 A YU02051/82 A YU 02051/82A YU 205182 A YU205182 A YU 205182A YU 205182 A YU205182 A YU 205182A
Authority
YU
Yugoslavia
Prior art keywords
alpha
beta
penam
methyl
carboxylic acid
Prior art date
Application number
YU02051/82A
Other languages
English (en)
Inventor
W E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU205182A publication Critical patent/YU205182A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
YU02051/82A 1981-09-14 1982-09-13 Process for obtaining 1,1-dioxide of 2-beta-subst.-2-alpha-methyl (5r)penam-3-alpha-carboxylic acid YU205182A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/301,995 US4356174A (en) 1981-09-14 1981-09-14 Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl-(5R)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor

Publications (1)

Publication Number Publication Date
YU205182A true YU205182A (en) 1985-03-20

Family

ID=23165806

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02051/82A YU205182A (en) 1981-09-14 1982-09-13 Process for obtaining 1,1-dioxide of 2-beta-subst.-2-alpha-methyl (5r)penam-3-alpha-carboxylic acid

Country Status (25)

Country Link
US (1) US4356174A (fr)
EP (1) EP0074783B1 (fr)
JP (1) JPS5859990A (fr)
KR (1) KR860001361B1 (fr)
AT (1) ATE14585T1 (fr)
AU (1) AU532401B2 (fr)
CA (1) CA1212378A (fr)
CS (1) CS236681B2 (fr)
DE (1) DE3265082D1 (fr)
DK (1) DK407882A (fr)
ES (1) ES8308566A1 (fr)
FI (1) FI823165L (fr)
GR (1) GR76726B (fr)
HU (1) HU186575B (fr)
IE (1) IE53819B1 (fr)
IL (1) IL66776A (fr)
IN (1) IN159366B (fr)
NO (1) NO823093L (fr)
NZ (1) NZ201895A (fr)
PH (1) PH19442A (fr)
PL (1) PL139272B1 (fr)
PT (1) PT75548B (fr)
SU (1) SU1272995A3 (fr)
YU (1) YU205182A (fr)
ZA (1) ZA826687B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760058A (en) * 1984-08-29 1988-07-26 Farmitalia Carlo Erba S.P.A. Penam derivatives
US4861768A (en) * 1986-02-27 1989-08-29 Taiho Pharmaceutical Company, Limited 2 β-substituted thiomethylpenicillin derivatives and their preparation and use
TW383308B (en) * 1993-08-24 2000-03-01 Hoffmann La Roche 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors
US6156745A (en) * 1997-12-29 2000-12-05 Research Corporation Technologies, Inc. 2β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors
US6407091B1 (en) * 1999-04-15 2002-06-18 Research Corporation Technologies, Inc. β-lactamase inhibiting compounds
US6916801B2 (en) * 2001-07-24 2005-07-12 Alamx, Llc 7-Alkylidene-3-substituted-3-cephem-4-carboxylates as β-lactamase inhibitors
JP2005525399A (ja) * 2002-04-04 2005-08-25 アラムクス エルエルシー セリンおよびメタロ−β−ラクタマーゼの阻害剤
KR100796131B1 (ko) * 2005-04-06 2008-01-21 후지쯔 가부시끼가이샤 휴대형 전자 기기
CN104650119B (zh) * 2015-02-10 2017-04-05 中国科学院长春应用化学研究所 一种β‑内酰胺化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1541832A (en) * 1976-02-11 1979-03-07 Beecham Group Ltd 2-substituted penam derivatives methods for their preparation and compisitions containing them
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE3265082D1 (en) 1985-09-05
FI823165L (fi) 1983-03-15
PT75548A (en) 1982-10-01
NO823093L (no) 1983-03-15
PT75548B (en) 1985-12-09
IE822232L (en) 1983-03-14
US4356174A (en) 1982-10-26
JPS5859990A (ja) 1983-04-09
PH19442A (en) 1986-04-18
AU532401B2 (en) 1983-09-29
JPS6153354B2 (fr) 1986-11-17
PL238200A1 (en) 1985-02-13
GR76726B (fr) 1984-08-30
PL139272B1 (en) 1987-01-31
KR840001581A (ko) 1984-05-07
HU186575B (en) 1985-08-28
ES515649A0 (es) 1983-09-16
KR860001361B1 (ko) 1986-09-16
EP0074783B1 (fr) 1985-07-31
ATE14585T1 (de) 1985-08-15
DK407882A (da) 1983-03-15
IL66776A (en) 1985-07-31
IN159366B (fr) 1987-05-09
ES8308566A1 (es) 1983-09-16
IE53819B1 (en) 1989-03-01
FI823165A0 (fi) 1982-09-13
CS236681B2 (en) 1985-05-15
SU1272995A3 (ru) 1986-11-23
ZA826687B (en) 1983-07-27
AU8833982A (en) 1983-03-24
NZ201895A (en) 1985-03-20
CA1212378A (fr) 1986-10-07
EP0074783A1 (fr) 1983-03-23

Similar Documents

Publication Publication Date Title
EG15129A (en) Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
GB2000138A (en) Therapeutic agents
YU205182A (en) Process for obtaining 1,1-dioxide of 2-beta-subst.-2-alpha-methyl (5r)penam-3-alpha-carboxylic acid
DE3853962D1 (de) Verfahren zur Kristallisation von Kalium-Clavulanat.
ES8305769A1 (es) Un procedimiento para la preparacion de bis-esteres de 1,1-alcanodioles.
SE8500965D0 (sv) Mellanprodukter for framstellning av beta-laktamasinhibitorer
GB2045755B (en) Process and intermediates for penicillanic acid 1,1-dioxide and esters thereof
IE820342L (en) Penicillins
DE3261759D1 (en) Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
DE3062787D1 (en) Novel process for the preparation of 6-aminopenicillanic acid-1,1-dioxide and its salts
DE3461800D1 (en) Beta-lactamase inhibiting 6-(alkoxyaminomethyl)penicillanic acid 1,1-dioxide and derivatives
PH19472A (en) Process and intermediates for penicillanic acid 1,1-dioxide and esters thereof